Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Blood (2014) 124 (21): 722.

https://doi.org/10.1182/blood.V124.21.722.722

Published: 2014

Journal Articles

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Kristin A Rand, PhD, M.P.H., Chi Song, M.S., Amie E. Hwang, PhD, M.P.H., Carol A. Huff, MD, Leon Bernal-Mizrachi, MD, Michael H Tomasson, MD, Sikander Ailawadhi, MD, David J. Van Den Berg, PhD, Xin Sheng, PhD, John J. Graff, PhD, M.S., David V. Conti, PhD, Todd Zimmerman, MD, Edward Peters, D.MD S.M, Sc.D., Seema Singhal, MD, Cathryn H. Bock, PhD, Karen Pawlish, M.P.H., Graham A Colditz, MD, Dr.PH., Xin Sheng, PhD, Alexander Stram, M.S., Sara S. Strom, PhD, Benjamin Rybicki, PhD, Rick Kittles, PhD, Howard Terebelo, DO, Janet Stanford, PhD, MPH, Phyllis J. Goodman, PhD, Sonja I Berndt, PhD, John Carpten, PhD, Anselm JM Hennis, MSc,PhD MRCP, FRCP, Lisa Chu, PhD, M.P.H., Graham Casey, PhD, W R Driver, MSPH, Eric A. Klein, MD, M. Christina Leske, MD MPH, Esther John, PhD, Adam Bryant Murphy, MD, Christine Neslund-Dudas, PhD, Victoria L. Stevens, PhD, Curtis Pettaway, MD, Wei Zheng, MD PhD MPH, Suh-Yuh Wu, M.A., John Witte, PhD, Siqun Lilly Zheng, MD, Jianfeng Xu, MD,Dr.PH, Nikhil C. Munshi, MD, Ann Hsing, PhD, Sue Ingles, PhD, Jayesh Mehta, MD, Lisa B. Signorello, PhD, Stephen Jacob Chanock, MD, Barbara Nemesure, PhD, Ann M Mohrbacher, MD, Nalini Janakiraman, MD, William J Blot, MD, Brian E. Henderson, MD, Laurence N. Kolonel, MD PhD, Kenneth C. Anderson, MD, Brian C-H Chiu, PhD, Jeffrey Zonder, MD, Robert Z. Orlowski, PhD MD, Sagar Lonial, MD, Daniel O. Stram, PhD, Christopher Haiman, Sc.D., Wendy Cozen, DO, MPH

Blood (2014) 124 (21): 2030.

https://doi.org/10.1182/blood.V124.21.2030.2030

Published: 2014

Journal Articles

High Throughput Sequencing-Based Pathogen Discovery In Multiple Myeloma

Akinyemi I. Ojesina, MBBS, PhD, Chandra Sekhar Pedamallu, PhD, Aleksandar Kostic, PhD, Joonil Jung, PhD, Daniel Auclair, PhD, Jens Lohr, MD, PhD, John Carpten, PhD, Gad Getz, Ph.D., Jonathan J Keats, PhD, Matthew Meyerson, MD, PhD

Blood (2013) 122 (21): 5322.

https://doi.org/10.1182/blood.V122.21.5322.5322

Published: 2013

Journal Articles

Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles

Blood (2013) 122 (21): 532.

https://doi.org/10.1182/blood.V122.21.532.532

Published: 2013

Journal Articles

Gene Expression Profiling Of Multiple Myeloma Samples Using RNA Sequencing Identifies Frequent Rearrangements Of FCHSD2

Venkata D Yellapantula, MS, Christopher Murray, Winnie Liang, PhD, Daniel Auclair, PhD, Joan Levy, PhD, John Carpten, PhD, Jonathan J Keats, PhD

Blood (2013) 122 (21): 534.

https://doi.org/10.1182/blood.V122.21.534.534

Published: 2013

Journal Articles

The Myeloma Genome in Drug Refractory Extra-Medullary Disease Identifies Mutations in Proteasome, Cereblon and Glucocorticoid Pathways

Jan Egan, PhD, Klaus Martin Kortuem, MD, Chang-Xin Shi, PhD, Jessica Schmidt, David Craig, PhD, John Carpten, PhD, Keith Stewart, MBA, MB, CHB

Blood (2012) 120 (21): 3968.

https://doi.org/10.1182/blood.V120.21.3968.3968

Published: 2012

Journal Articles

The Multiple Myeloma Research Foundation (MMRF) CoMMpass SM Study: A Longitudinal Study in Newly-Diagnosed Multiple Myeloma Patients to Assess Genomic Profiles, Immunophenotypes and Clinical Outcomes

Michael N. Needle, MD, Beverly Harrison, Carolyn Hoban, DSc, Pamela G. Kidd, MD, Scott Jewell, PhD, Thomas Monroe, PhD, Jonathan J Keats, PhD, John Carpten, PhD, Louise M. Perkins, PhD, Kenneth Anderson, MD, Sagar Lonial, MD

Blood (2012) 120 (21): 3980.

https://doi.org/10.1182/blood.V120.21.3980.3980

Published: 2012

Journal Articles

CpG Methylation Profiling in Multiple Myeloma.

Bodour Salhia, PhD, Angela Baker, PhD, Jonathan J Keats, PhD, Gregory Ahmann, BS, Daniel Auclair, PhD, Bunmi Mfuko, Louise M. Perkins, PhD, Joan Levy, PhD, Leif Bergsagel, MD, Rafael Fonseca, MD, John Carpten, PhD

Blood (2009) 114 (22): 604.

https://doi.org/10.1182/blood.V114.22.604.604

Published: 2009

Journal Articles

Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma.

Jonathan Keats, PhD, Mike Chapman, PhD, John Carpten, PhD, Wee-Joo Chng, MD, Angela Baker, PhD, Gregory Ahmann, Suzanne Trudel, MD, David Siegel, MD, PhD, S. Vincent Rajkumar, MD, Melissa Alsina, MD, Paul Richardson, MD, Kenneth Anderson, MD, Daniel Auclair, PhD, Louise M. Perkins, PhD, Jeffrey Trent, PhD, Todd R. Golub, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 396.

https://doi.org/10.1182/blood.V110.11.396.396

Published: 2007

Journal Articles

RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines.

Travis J. Henry, PhD, Wee Joo Chng, MD, John Carpten, PhD, P. Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2489.

https://doi.org/10.1182/blood.V110.11.2489.2489

Published: 2007

Journal Articles

The Multiple Myeloma Research Consortium Genomics Initiative.

Jeffrey Trent, PhD, John Carpten, PhD, Michael Reich, PhD, Ted Liefeld, PhD, Jonathan Keats, PhD, Spyro Mousses, PhD, William Hahn, MD, PhD, Suzanne Trudel, MD, David Siegel, PhD, S. Vincent Rajkumar, MD, Melissa Alsina, MD, Paul Richardson, MD, Kenneth Anderson, MD, Daniel Auclair, PhD, Louise M. Perkins, PhD, Kathy Giusti, Rafael Fonseca, MD, Todd R. Golub, MD

Blood (2007) 110 (11): 2498.

https://doi.org/10.1182/blood.V110.11.2498.2498

Published: 2007

Journal Articles

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Wee J. Chng, MD, Jonathan J. Keats, PhD, Esteben Braggio, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 1476.

https://doi.org/10.1182/blood.V110.11.1476.1476

Published: 2007

Journal Articles

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Wee J. Chng, MD, Tae-Hoon Chung, PhD, Jonathan J. Keats, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2471.

https://doi.org/10.1182/blood.V110.11.2471.2471

Published: 2007

Journal Articles

Inactivation of Tumor Necrosis Factor 3 Gene (TRAF3) Is Frequently Identified in Waldenström’s Macroglobulinemia Patients.

Esteban Braggio, PhD, Jonathan J. Keats, PhD, Scott Van Wier, Tammy Price-Troska, Kimberly Henderson, Marta Chesi, PhD, John Carpten, PhD, Leif P. Bergsagel, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2476.

https://doi.org/10.1182/blood.V110.11.2476.2476

Published: 2007

Journal Articles

Comparative High Resolution Array-Based CGH (aCGH) in B-Cell Malignancies.

Esteban Braggio, PhD, Jonathan J. Keats, PhD, Wee-Joo Chng, MD, Victor H. Jimenez, MD, Roelandt Schop, MD, Alexander Sekulik, MD, PhD, Angela Baker, Scott Van Wier, Tammy Price-Troska, Michael Barrett, PhD, John Carpten, PhD, Ellen Remstein, MD, Ahmet Dogan, MD, Leif P. Bergsagel, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2479.

https://doi.org/10.1182/blood.V110.11.2479.2479

Published: 2007

Journal Articles

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Blood (2006) 108 (11): 3407.

https://doi.org/10.1182/blood.V108.11.3407.3407

Published: 2006

Journal Articles

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Wee-Joo Chng, MD, Angela Baker, PhD, Travis Henry, PhD, Tammy Price-Troska, Scott Van Wier, Tae-Hoon Chung, PhD, Kim Henderson, Gregory Ahmann, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2006) 108 (11): 113.

https://doi.org/10.1182/blood.V108.11.113.113

Published: 2006

Journal Articles

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

Blood (2006) 108 (11): 109.

https://doi.org/10.1182/blood.V108.11.109.109

Published: 2006

Journal Articles

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Tae-Hoon Chung, Seungchan Kim, PhD, John Carpten, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Robert Kyle, MD, Philip Greipp, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1538.

https://doi.org/10.1182/blood.V106.11.1538.1538

Published: 2005

Journal Articles

MicroRNA Expression Analysis in Multiple Myeloma.

Azzah Al Masri, PhD, Tammy Price-Troska, Marta Chesi, PhD, Tae-Hoon Chung, PhD, Seungchan Kim, PhD, John Carpten, PhD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1554.

https://doi.org/10.1182/blood.V106.11.1554.1554

Published: 2005

NARROW

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

High Throughput Sequencing-Based Pathogen Discovery In Multiple Myeloma

Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles

Gene Expression Profiling Of Multiple Myeloma Samples Using RNA Sequencing Identifies Frequent Rearrangements Of FCHSD2

The Myeloma Genome in Drug Refractory Extra-Medullary Disease Identifies Mutations in Proteasome, Cereblon and Glucocorticoid Pathways

The Multiple Myeloma Research Foundation (MMRF) CoMMpass SM Study: A Longitudinal Study in Newly-Diagnosed Multiple Myeloma Patients to Assess Genomic Profiles, Immunophenotypes and Clinical Outcomes

CpG Methylation Profiling in Multiple Myeloma.

Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma.

RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines.

The Multiple Myeloma Research Consortium Genomics Initiative.

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Inactivation of Tumor Necrosis Factor 3 Gene (TRAF3) Is Frequently Identified in Waldenström’s Macroglobulinemia Patients.

Comparative High Resolution Array-Based CGH (aCGH) in B-Cell Malignancies.

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

MicroRNA Expression Analysis in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only